PCL, Inc. (241820)の価格はいくらですか

PCL, Inc. (241820)の価格は$0.21291741です

PCL, Inc. (241820)の時価総額は何ですか

PCL, Inc. (241820)の時価総額は$12.07Mです

PCL, Inc.（241820）PBR（株価純資産倍率）

PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.

年	P/B比率	変化
2026 (TTM)	0.31	-92.92%
2024	4.37	0.92%
2023	4.33	-22.84%
2022	5.61	-79.76%
2021	27.74	158.91%
2020	10.71	-23.63%
2019	14.03	43.20%
2018	9.80	-11.87%
2017	11.12	-9.46%
2016	12.28	-33.14%
2015	18.36	0.00%

年

P/B比率

変化

2026 (TTM)

0.31

-92.92%

2024

4.37

0.92%

2023

4.33

-22.84%

2022

5.61

-79.76%

2021

27.74

158.91%

2020

10.71

-23.63%

2019

14.03

43.20%

2018

9.80

-11.87%

2017

11.12

-9.46%

2016

12.28

-33.14%

2015

18.36

0.00%

企業	P/B比率	P/B比率の差	国
Abbott Laboratories ABT.US	3.7944	1,126.37%	US
Stryker Corporation SYK.US	5.423	1,652.75%	US
Medtronic plc MDT.US	2.0146	551.13%	IE
Boston Scientific Corporation BSX.US	3.072	892.89%	US
Edwards Lifesciences Corporation EW.US	4.9725	1,507.14%	US

企業

P/B比率

P/B比率の差

国